Cleared Traditional

K062473 - LIAISON BORRELIA IGG/IGM ASSAY, MODEL 310870

Also marketed or referenced as:
SERUM CONTROLS, MODEL 310871

K062473 is an FDA 510(k) clearance for LIAISON BORRELIA IGG/IGM ASSAY, manufactured by DiaSorin, Inc.. The device is a Class 2 Microbiology device with product code LSR cleared through the Traditional 510(k) pathway after a 231-day FDA review.

K062473 · DiaSorin, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2007
Decision
231d
Days
Class 2
Risk

K062473 is an FDA 510(k) clearance for the LIAISON BORRELIA IGG/IGM ASSAY, MODEL 310870. Classified as Reagent, Borrelia Serological Reagent (product code LSR), Class II - Special Controls.

Submitted by DiaSorin, Inc. (Stillwater, US). The FDA issued a Cleared decision on April 12, 2007 after a review of 231 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3830 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all DiaSorin, Inc. devices

FDA 510(k) Submission Details - K062473

510(k) Number K062473 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 24, 2006
Decision Date April 12, 2007
Days to Decision 231 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
129d slower than avg
Panel avg: 102d · This submission: 231d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LSR Device Classification - Class 2, Special Controls

Product Code LSR Reagent, Borrelia Serological Reagent
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3830
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LSR Reagent, Borrelia Serological Reagent

All 97
Devices cleared under the same product code (LSR) and FDA review panel - the closest regulatory comparables to K062473.
ATHENA MULTI-LYTE BORRELIA VLSE-1/PEPC10 PLUS TEST SYSTEM
K100728 · Zeus Scientific, Inc. · Jul 2010
PLATELIA LYME IGM
K081362 · Bio-Rad · Jun 2008
PLATELIA LYME IGG ASSAY
K080012 · Bio-Rad · May 2008
VIRAMED BIOTECH BORRELIA B31 IGG VIRABLOT
K051071 · Viramed Biotech AG · Aug 2005
BIRAMED BIOTECH BORRELIA B31 IGM VIRABLOT
K051169 · Viramed Biotech AG · Aug 2005
QUANTA LITE LYME B. BURGDORFERI IGG/IGM ELISA KIT
K994004 · Inova Diagnostics, Inc. · Jan 2000